According to the latest report by IMARC Group,the global pneumococcal vaccine market size grew at a CAGR of 5% during 2015-2020.Pneumococcal vaccines are used to enhance immunization against the bacterium streptococcus pneumoniae that causes meningitis, sepsis and pneumonia. There are two types of pneumococcal vaccines, namely pneumococcal conjugate (PCV13) and pneumococcal polysaccharide vaccine (PPSV23).

1. Copyright © IMARC Service Pvt Ltd. All Rights Reserved
Global Pneumococcal Vaccine
Market Research Report and
Forecast 2021-2026
Author: Elena Anderson,
Marketing Manager |
IMARC Group
© 2019 IMARC All Rights Reserved

2. Report Description
About IMARC Group
The International Market Analysis Research and Consulting Group is a leading adviser on
management strategy and market research worldwide. We partner with clients in all sectors
and regions to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our
clients achieve unmatchable competitive advantage, build more proficient organizations, and
secure lasting results.

3. Report Description
Report Description and Highlights
Global Pneumococcal Vaccine Market Outlook 2026:
According to the latest report by IMARC Group, titled "Pneumococcal Vaccine Market: Global Industry
Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026," the global pneumococcal vaccine
market size grew at a CAGR of 5% during 2015-2020.
Pneumococcal vaccines are used to enhance immunization against the bacterium streptococcus
pneumoniae that causes meningitis, sepsis and pneumonia. There are two types of pneumococcal
vaccines, namely pneumococcal conjugate (PCV13) and pneumococcal polysaccharide vaccine
(PPSV23).
These vaccines stimulate the immune system response of an individual to produce antibodies against
the bacteria, which helps to prevent the spread of the infection, reduce fatality rate, and eliminate the
need for emergency hospitalization.
Request for a free sample: https://www.imarcgroup.com/pneumococcal-vaccine-
market/requestsample

4. Report Description
Report Description and Highlights
Global Pneumococcal Vaccine Market Trends:
The increasing prevalence of pneumococcal diseases in young children and the rising geriatric
population represents the key factor driving the market growth. This is further supported by the
introduction of PCV13 in infant routine immunization by the healthcare sector.
Additionally, the rising number of smokers, who are more prone to developing pneumonia, is acting as
a growth-inducing factor. Moreover, governments of various nations are creating awareness and
organizing immunization programs across the globe for the prevention of the disease, which is
contributing to the market growth.
In line with this, the sudden outbreak of coronavirus disease (COVID-19) has escalated the utilization of
pneumococcal vaccines as a preventive measure against increasing lung infections.

5. Market Summary:
Breakup by Vaccine Type:
• Pneumococcal Conjugate Vaccine
• Pneumococcal Polysaccharide Vaccine
Breakup by Product Type:
• Prevnar 13
• Synflorix
• Pneumovax 23
Breakup by End User:
• Pediatrics
• Adults
Report Description
Report Description and Highlights

6. Breakup by Distribution Channel:
• Distribution Partner Companies
• Non-Governmental Organizations (NGO)
• Government Authorities
Breakup by Region:
• North America
• Asia Pacific
• Europe
• Middle East and Africa
• Latin America
Looking forward, the market is expected to exhibit moderate growth during 2021-2026.
Report Description
Report Description and Highlights

7. Competitive Landscape With Key players:
• Astellas Pharma Inc
• GlaxoSmithKline Plc
• Merck & Co. Inc
• Panacea Biotec Ltd
• Pfizer Inc
• Sanofi S.A
• Serum Institute of India Pvt Ltd
• Walvax Biotechnology Co. Ltd
View Report TOC, Figures and Tables: https://www.imarcgroup.com/pneumococcal-vaccine-market
Report Description
Report Description and Highlights

8. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

9. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

10. Report Description
Report Description and Highlights
© 2019 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.

11. FOR MORE DETAILS
Visit us at :
Stay With Us:
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com
https://www.imarcgroup.com
Contact Us